To validate the role of FoxO3, we silenced FoxO3 expression via siRNAs in PLOD3-KD Trastuzumab-resistant GC cells, and measured p21, PCNA, and cleaved Caspase3 expression via immunoblot assays. The gene discussed is FOXO3; the disease is gastric cancer.